NDC 70121-1627

FYLNETRA

Pegfilgrastim

FYLNETRA is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Pegfilgrastim.

• Product ID: 70121-1627_56c3c6dd-ecf2-48f4-b247-181d122e362a
• NDC: 70121-1627
• Product Type: Human Prescription Drug
• Proprietary Name: FYLNETRA
• Generic Name: Pegfilgrastim
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2022-05-31
• Marketing Category: BLA /
• Application Number: BLA761084
• Labeler Name: Amneal Pharmaceuticals LLC
• Substance Name: PEGFILGRASTIM
• Active Ingredient Strength: 6 mg/.6mL
• Pharm Classes: Granulocyte Colony-Stimulating Factor [CS], Granulocyte-Macrophage Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 70121-1627-1

1 SYRINGE in 1 CARTON (70121-1627-1) > .6 mL in 1 SYRINGE

• Marketing Start Date: 2022-05-31
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "FYLNETRA" or generic name "Pegfilgrastim"

NDC	Brand Name	Generic Name
70121-1627	FYLNETRA	pegfilgrastim
67457-833	Fulphila	pegfilgrastim
55513-190	Neulasta	pegfilgrastim
55513-192	Neulasta	pegfilgrastim